Literature DB >> 15583869

TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation.

E M Esparza1, R H Arch.   

Abstract

Members of the tumor necrosis factor receptor (TNFR) family regulate the activation, differentiation, and function of many cell types, including cells of the immune system. TNFR-associated factors (TRAFs) function as adapter molecules controlling signaling pathways triggered by TNFR family members, such as activation of nuclear factor kappaB (NF-kappaB). Despite intensive research, the function of TRAF4 in signaling pathways triggered by TNFR-related proteins remains enigmatic. Intriguingly, our functional studies indicated that TRAF4 augments NF-kappaB activation triggered by glucocorticoid-induced TNFR (GITR), a receptor expressed on T cells, B cells, and macrophages. Further analyses revealed that TRAF4-mediated NF-kappaB activation downstream of GITR depends on a previously mapped TRAF-binding site in the cytoplasmic domain of the receptor and is inhibited by the cytoplasmic protein A20. GITR is thought to inhibit the suppressive function of regulatory T cells (Treg cells) and to promote activation of T cells. Taken together, our studies provide the first indications that TRAF4 elaborates GITR signaling and suggest that TRAF4 can modulate the suppressive functions of Treg cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583869     DOI: 10.1007/s00018-004-4417-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  68 in total

1.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

2.  Undiagnosed NIDDM: clinical and public health issues.

Authors:  M I Harris
Journal:  Diabetes Care       Date:  1993-04       Impact factor: 19.112

3.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

4.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

5.  The diabetes risk score: a practical tool to predict type 2 diabetes risk.

Authors:  Jaana Lindström; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

6.  Assessing the impact of complications on the costs of Type II diabetes.

Authors:  R Williams; L Van Gaal; C Lucioni
Journal:  Diabetologia       Date:  2002-06-12       Impact factor: 10.122

7.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy.

Authors:  I-Min Lee; Eric J Shiroma; Felipe Lobelo; Pekka Puska; Steven N Blair; Peter T Katzmarzyk
Journal:  Lancet       Date:  2012-07-21       Impact factor: 79.321

8.  Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort.

Authors:  M Rahman; R K Simmons; S H Hennings; N J Wareham; S J Griffin
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

9.  Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK.

Authors:  Linda Penn; Martin White; John Oldroyd; Mark Walker; K George M M Alberti; John C Mathers
Journal:  BMC Public Health       Date:  2009-09-16       Impact factor: 3.295

10.  Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.

Authors:  Rebecca K Simmons; Justin B Echouffo-Tcheugui; Stephen J Sharp; Lincoln A Sargeant; Kate M Williams; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  Lancet       Date:  2012-10-04       Impact factor: 79.321

View more
  23 in total

1.  Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.

Authors:  Takanori So; Pejman Soroosh; So-Young Eun; Amnon Altman; Michael Croft
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Role for Traf4 in polarizing adherens junctions as a prerequisite for efficient cell shape changes.

Authors:  Sam J Mathew; Martina Rembold; Maria Leptin
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

3.  TRAF4 is a critical molecule for Akt activation in lung cancer.

Authors:  Wei Li; Cong Peng; Mee-Hyun Lee; DoYoung Lim; Feng Zhu; Yang Fu; Ge Yang; Yuqiao Sheng; Lanbo Xiao; Xin Dong; WeiYa Ma; Ann M Bode; Ya Cao; Zigang Dong
Journal:  Cancer Res       Date:  2013-10-23       Impact factor: 12.701

4.  The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection.

Authors:  Massimiliano Agostini; Elio Cenci; Eva Pericolini; Giuseppe Nocentini; Giovanni Bistoni; Anna Vecchiarelli; Carlo Riccardi
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 5.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

Review 6.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Characterization of immune functions in TRAF4-deficient mice.

Authors:  Julien Cherfils-Vicini; Benoit Vingert; Audrey Varin; Eric Tartour; Wolf-Herman Fridman; Catherine Sautès-Fridman; Catherine H Régnier; Isabelle Cremer
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

8.  Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation.

Authors:  Tuzer Kalkan; Yasuno Iwasaki; Chong Yon Park; Gerald H Thomsen
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

9.  Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.

Authors:  Baoying Liu; Zhuqing Li; Sankaranarayana P Mahesh; Seth Pantanelli; Frank S Hwang; Willie O Siu; Robert B Nussenblatt
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

10.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.